… (MACE) by 13% in patients at high cardiovascular risk with … The effects of bempedoic
acid on total cardiovascular events … In summary, this prespecified analysis of the CLEAR Out…

… Prespecified sensitivity analyses confirmed the LDL-C … The results of this study reinforce
observations from the similarly designed CLEAR Harmony clinical trial in which bempedoic acid …

… reduced the risk of major adverse cardiovascular events … , double-blind, placebo-controlled
trial conducted across 1250 … , there was no effect of bempedoic acid treatment on HbA 1c or …

… the CLEAR (Cholesterol Lowering via Bempedoic Acid [… Results of a prespecified
subgroup analysis of the primary … The effects of bempedoic acid on cardiovascular events in …

… a prespecified subgroup analysis of the effects of bempedoic … to perform clinical research
related to bempedoic acid; … the steering committee for CLEAR Outcomes trial. Dr Libby reported …

… than the total number of events a patient may have experienced, which was the subject of
a recent pre-specified analysis of CLEAR – Outcomes showing a reduction in total events [7]. …

… We discuss the clinical implications and conclude with future … bempedoic acid compared
to 10.1% in the placebo group. … events (prespecified analysis) and total endpoint events (post …

… -up, prespecified sensitivity analyses of primary clinical efficacy … -analysis of BAs efficacy for
prevention of CV events and … patients: a meta-analysis of randomized controlled trials. BMC …

… cardiovascular event, 30 this finding supports a positive effect of BA on overall cardiovascular
… disease (CLEAR [Cholesterol Lowering via Bempedoic Acid, an ACL‐Inhibiting Regimen] …

… for primary or secondary prevention of cardiovascular events. … Predefined muscle‐related
adverse events occurred in 12.8… The durability of effect and safety of extended bempedoic acid …